Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Definition of Hypercoagulability, estrogen-associated

Hypercoagulability, estrogen-associated: Hypercoagulability (a supranormal tendency for blood to clot) occurs as an occasional but serious side effect of estrogen therapy.

The blood clots in this situation are dose-related, that is, they occur more frequently with higher doses of estrogen.

Estrogen therapy preparations (all of which carry this risk) include:

The brand names of the estrogen therapy preparations carrying this risk include:

  • CLIMARA (estradiol)
  • ESTRACE (estradiol)
  • ESTRADERM (estradiol)
  • ESTRATAB (esterified estrogens)
  • ESTRATEST (esterified estrogens and methyltestosterone)
  • MENEST (esterified estrogens)
  • OGEN (estropipate)
  • PREMARIN (estrogens conjugated)
  • PREMPHASE (estrogens conjugated and medroxyprogesterone)
  • PREMPRO (estrogens conjugated and medroxyprogesterone)

Cigarette smokers on estrogen therapy are at a higher risk than non-smokers for blood clots. Therefore, patients requiring estrogen therapy are strongly encouraged to quit smoking.

QUESTION

Salt and sodium are the same. See Answer

From WebMD Logo

Heart Health Resources
Health Solutions From Our Sponsors
Reviewed on 12/27/2018

Health Solutions From Our Sponsors